NewsBenzingainTest Q3 BPA ajustado de 0,18 $ supera la estimación de 0,12 $, ventas de 35,069 millones de $ superan la estimación de 34,800 millones de $ inTest Q3 BPA ajustado de 0,18 $ supera la estimación de 0,12 $, ventas de 35,069 millones de $ superan la estimación de 34,800 millones de $ Benzinga 2026.11.06 11:16 (GMT+0) Open on Benzinga Other news Piper Sandler Maintains Overweight on ICU Medical, Raises Price Target to $200 Keybanc Maintains Overweight on Five9, Raises Price Target to $34 Piper Sandler Maintains Neutral on Collegium Pharmaceutical, Lowers Price Target to $28 Keybanc Maintains Overweight on FIGS, Raises Price Target to $27 Reported Earlier, Kazakhstan Says Oil Exports To Germany Won't Resume By End Of 2026 Piper Sandler Maintains Neutral on Becton Dickinson, Raises Price Target to $200
